Tuesday, March 31, 2015

Ranbaxy recalls some of its generic Lipitor in the U.S.

Ranbaxy recalls certain lots of its generic version of Lipitor in the United States.

Ranbaxy recalls some of its generic Lipitor in the U.S.

Ranbaxy Pharmaceuticals Inc., the U.S. subsidiary of the Indian drugmaker, said Friday it is recalling some bottles of its generic version of the cholesterol medicine Lipitor, the chemical name of which is atorvastatin calcium.

Some bottles being recalled might contain “small glass particles less than 1 mm in size,” according to a statement on the company website.

Ranbaxy, whose U.S. headquarters is in Princeton, said the recall involves some 90- and 500-count bottles in the 10mg 20mg and 40mg dosage.

The recalled lot numbers, which are printed on the package label, can be found on www.ranbaxyusa.com. The recall does not involve pills in the 80 mg strength.

David Sell
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Business Videos:
Also on Philly.com:
Stay Connected